We’ve seen the first AI-generated commercials, songs and even social media influencers outside of healthcare. Will pharma be ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

The pharmaceutical industry is experiencing a profound transformation in how it approaches commercial decision-making and insights delivery with a big wave of technology and AI at the doorstep. Market ...

Indian pharmaceutical market (IPM) has registered a growth of 8.1 percent to touch ₹2,40,672 crore in 2025 and is likely to ...

Regeneron Pharmaceuticals (NASDAQ: REGN) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

In the not too distant past, pharma lagged behind consumer advertising’s ability to churn out cutting-edge creativity. Weighed down by the regulatory, safety and compliance aspects that are par for ...

In FY25, India's pharmaceutical exports reached a record high, surpassing $30 billion (approximately $30.47 billion), a ...

Madrigal’s Rezdiffra tops $1B run-rate in MASH, but losses and rising GLP-1/FGF21 competition may cap upside into 2026. See ...

This fall, Fierce Pharma Marketing launched a running series of Q&A features celebrating up-and-comers in our corner of the industry. Each of the “Rising Stars” profiles spotlights a different ...

The Indian Pharmaceutical Market closed 2025 at Rs 2,40,672 crore with 8.1% value growth. A similar 7.8-8.1% growth is ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $496.45, a high estimate of $564.00, and a low estimate of $414.00. Witnessing a positive shift, the ...